Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model

Carcinogenesis

Volumn 29, Issue 11, 2008, Pages 2218-2226

  Takahashi, Miwa ^a   Shibutani, Makoto ^a,b   Woo, Gye Hyeong ^a   Inoue, Kaoru ^a   Fujimoto, Hitoshi ^a   Igarashi, Katsuhide ^a   Kanno, Jun ^a   Hirose, Masao ^a,c   Nishikawa, Akiyoshi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c Food Safety Commission of Japan   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; CELL NUCLEUS RECEPTOR; FENBENDAZOLE; GLUTATHIONE TRANSFERASE; HYPOCALCIN; INTERLEUKIN 1BETA; IRON; MINICHROMOSOME MAINTENANCE PROTEIN 6; PHENOBARBITAL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN ARGININE METHYLTRANSFERASE; SYNTAXIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSGELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE MUTATION; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 56049099758     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn135     Document Type: Article

References (37)

1. Tatematsu,M. et al. (1985) Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis, 6, 1621-1626.
2. Kitano,M. et al. (2006) Possible tumor development from double positive foci for TGF-α and GST-P observed in early stages on rat hepatocarcinogenesis. Cancer Sci., 97, 478-483.
3. Reisenbichler,H. et al. (1994) Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors. Carcinogenesis, 15, 2763-2767.
4. Ueno,T. et al. (2001) Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. Int. J. Oncol., 18, 49-55.
5. Breuhahn,K. et al. (2006) Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene, 25, 3787-3800.
6. Lim,I.K. et al. (1999) Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in Fischer 344 male rats by reciprocal expression of transforming growth factor-β1 and its receptors. Mol. Carcinog., 26, 83-92.
7. Park,D.Y. et al. (2001) Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats. Toxicol. Pathol., 29, 541-549.
8. Fabregat,I. et al. (2007) Survival and apoptosis; a dysregulated balance in liver cancer. Liver Int., 27, 155-162.
9. Wang,L. et al. (2007) Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol. Res., 37, 389-396.
10. Silins,I. et al. (2006) Dietary sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho-Akt and high levels of ceramide species. Food Chem. Toxicol., 44 1552-1561.
11. Shoda,T. et al. (1999) Liver tumor promoting effects of fenbendazole in rats. Toxicol. Pathol, 27, 553-562.
12. Tatematsu,M. et al. (1988) Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis, 9, 221-225.
13. Shirai,T. (1997) A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential, a historical review of model development and summary of results from 291 tests. Toxicol. Pathol. 25, 453-460.
14. Ito,N. et al. (2000) Early detection of carcinogenic substances and modifiers in rats. Mutat. Res., 462, 209-217.
15. Kinoshita,A. et al. (2003) Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis, 24, 1389-1399.
16. Whysner,J. et al. (1996) Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther., 71, 153-191.
17. Ong,C.K. et al. (2004) Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J. Biol. Chem. 279, 743-754.
18. Gilbreth,M. et al. (1998) Negative regulation of mitosis in fission yeast by the shk1 interacting protein skb1 and its human homolog, Skb1Hs. Proc. Natl Acad. Sci. USA., 95, 14781-14786.
19. Brondello,J.M. et al. (1999) Reduced MAP kinase phosphatase-1 degradation after p42/p42MAPK-dependent phosphorylation. Science, 286, 2514-2517.
20. Schrader,C. et al. (2005) Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br. J. Cancer, 93, 9399-45.
21. Ponka,P. et al. (1999) The transferrin receptor: Role in health and disease. Int. J. Biochem. Cell Biol., 31, 1111-1137.
22. Pascale,R.M. et al. (1998) Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat. Hepatology, 27, 452-461.
23. Holmström,P. et al. (2006) Expression of iron regulatory genes in a rat model of hepatocellular carcinoma. Liver Int., 26, 976-985.
24. Seol,W. et al. (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science, 272, 1336-1339.
25. Kim,J.Y. et al. (2004) Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding. Mol. Endocrinol., 18, 2880-2894.
26. Sawaki,M. et al. (1990) Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis, 11, 1857-1861.
27. Bomford,A.B. et al. (1985) Transferrin and its receptor: Their roles in cell function. Hepatology, 5, 870-875.
28. Wrba,F. et al. (1989) Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study. Oncology 46, 255-259.
29. Mansbach,J.M. et al. (1996) Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels. Carcinogenesis 17, 171-174.
30. Akhurst,R.J. et al. (2001) TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol., 11, S44-S51.
31. Huang,S.S. et al. (2005) TGF-beta control of cell proliferation. J. Cell Biochem., 96, 447-462.
32. Park,D.Y. et al. (2003) Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats. J. Korean Med. Sci., 18, 510-519.
33. Park,Y.N. et al. (2004) Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: Resistance mechanism to transforming growth factorbeta. Hepatogastroenterology, 51, 396-400.
34. Hu,T.H. et al. (2003) Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97, 1929-1940.
35. Shigeoka,Y. et al. (2004) Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition. J. Cancer Res. Clin. Oncol., 130, 146-152.
36. Hjelmeland,A.B. et al. (2005) Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. Cancer Res., 65 11276-11281.
37. Wu,H. et al. (2003) PTEN signaling pathways in melanoma. Oncogene, 22, 3113-3122.